BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 17950026)

  • 21. Cancer chemoprevention by the antioxidant tempol in Atm-deficient mice.
    Schubert R; Erker L; Barlow C; Yakushiji H; Larson D; Russo A; Mitchell JB; Wynshaw-Boris A
    Hum Mol Genet; 2004 Aug; 13(16):1793-802. PubMed ID: 15213104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of antioxidants on radiation-induced apoptosis pathways in TK6 cells.
    Samuni AM; DeGraff W; Cook JA; Krishna MC; Russo A; Mitchell JB
    Free Radic Biol Med; 2004 Nov; 37(10):1648-55. PubMed ID: 15477016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of catecholaminergic oxidative toxicity by 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl and its recycling complex with polynitroxylated albumin, TEMPOL/PNA.
    Weinberg A; Nylander KD; Yan C; Ma L; Hsia CJ; Tyurin VA; Kagan VE; Schor NF
    Brain Res; 2004 Jun; 1012(1-2):13-21. PubMed ID: 15158156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tempicol-2 (4-hydroxy-4-(2-picolyl)-2,2,6,6-tetramethylpiperidine-1-oxyl), a stable free radical, is a novel member of nitroxide class of antioxidants and anticancer agents.
    Metodiewa D; Skolimowski J; Kochman A; Gwozdzinski K; Głebska J
    Anticancer Res; 1998; 18(1A):369-77. PubMed ID: 9568105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The nitroxide antioxidant Tempol affects metal-induced cyto- and genotoxicity in human lymphocytes in vitro.
    Lewinska A; Wnuk M; Slota E; Bartosz G
    Mutat Res; 2008 Jan; 649(1-2):7-14. PubMed ID: 17950026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytokinesis-block micronucleus assay evolves into a "cytome" assay of chromosomal instability, mitotic dysfunction and cell death.
    Fenech M
    Mutat Res; 2006 Aug; 600(1-2):58-66. PubMed ID: 16822529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of tempol on endothelium-dependent vasodilatation and blood pressure.
    Simonsen U; Christensen FH; Buus NH
    Pharmacol Ther; 2009 May; 122(2):109-24. PubMed ID: 19268689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antioxidant evaluation of heterocyclic compounds by cytokinesis-block micronucleus assay.
    Godevac D; Tesević V; Vajs V; Milosavljević S; Stanković M
    Mini Rev Med Chem; 2013 Mar; 13(3):431-8. PubMed ID: 23061623
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 30.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.